Literature DB >> 8976231

Comparative cost analysis of collagen injection and fascia lata sling cystourethropexy for the treatment of type III incontinence in women [ssee comments].

C J Berman1, K J Kreder.   

Abstract

PURPOSE: We examined the cost of 2 common forms of surgical treatment of genuine stress urinary incontinence due to intrinsic sphincter deficiency, that is sling cystourethropexy and periurethral collagen injection.
MATERIALS AND METHODS: Between May 1994 and July 1995, 14 women with intrinsic sphincter deficiency underwent sling cystourethropexies. A total of 14 matched patients with intrinsic sphincter deficiency underwent endoscopic collagen injection during the same period.
RESULTS: The total cost per treatment of fascia lata sling cystourethropexy ($10,382) was 2.1 times greater than that for collagen injection ($4,996, p < 0.001). At an average followup of 14.9 months for fascia lata cystourethropexy and 21.3 months for collagen injection, 71.4% of patients in the former and 26.7% in the latter groups were completely continent (p = 0.05). One or no pads were used daily by 85 and 40% of the patients, respectively.
CONCLUSIONS: Fascia lata sling cystourethropexy may be a more cost-effective surgical treatment than periurethral endoscopic collagen injection for treating genuine stress urinary incontinence in women with intrinsic sphincter deficiency when the greater success rate of the former procedure is considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8976231

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

Review 2.  Pubovaginal slings: past, present and future.

Authors:  R Sarver; F E Govier
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 3.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 4.  The financial burden of stress urinary incontinence among women in the United States.

Authors:  Erin C Chong; Aqsa A Khan; Jennifer T Anger
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 5.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Haroon Rehman; Carlos A Bezerra; Homero Bruschini; June D Cody; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

6.  Factors influencing the long-term success of periurethral collagen therapy in the office.

Authors:  Sumana Koduri; Roger P Goldberg; Christina Kwon; Deborah G Dobrez; Peter K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-14

7.  Collagen injections for genuine stress urinary incontinence: patient selection and durability.

Authors:  S Herschorn; S B Radomski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

8.  Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and cost.

Authors:  Gisela Kobelt; Aino Fianu-Jonasson
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

9.  Traditional suburethral sling operations for urinary incontinence in women.

Authors:  Lucky Saraswat; Haroon Rehman; Muhammad Imran Omar; June D Cody; Patricia Aluko; Cathryn Ma Glazener
Journal:  Cochrane Database Syst Rev       Date:  2020-01-28

Review 10.  Injectable agents: present and future.

Authors:  Deborah J Lightner; Nancy B Itano; Susan D Sweat; Kristin L Chrouser; Felecia Fick
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.